How Mindset Pharma Is Making and Defining ‘Next-Generation Psychedelic Drugs’
CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company’s lead candidate may be better than psilocybin.
CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company’s lead candidate may be better than psilocybin.
Planting, cultivating, purchasing, transporting, distributing, possessing these plants and fungi will be the lowest law enforcement priority for the city.
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat Parkinson’s Disease.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.